AI-generated summary
The authors compared three melasma treatment approaches in 52 women: fractional CO2 laser or microneedling combined with tranexamic acid gel, laser alone, and a nanotechnology-based tranexamic acid microemulsion applied daily. All groups showed reductions in clinical, dermoscopic and SOX10 scores, with the laser-assisted and microemulsion groups improving more than the laser-alone side. The authors report no recurrence during three-month follow-up and describe the microemulsion as effective and safe.
- Participants
- 52
- Who or what was studied
- 52 adult females with melasma
- Limits stated in the abstract
- The abstract reports a small sample split into three groups with unequal sizes, a three-month follow-up, and does not describe the wavelength or safety data in detail.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.